These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

468 related items for PubMed ID: 36056599

  • 21. FOXD3 suppresses epithelial-mesenchymal transition through direct transcriptional promotion of SMAD7 in esophageal squamous cell carcinoma.
    Wu Z, Li Y, Niu Y, Lu J, Yan Z, Xu T, Guo Y, Dong Z, Guo W.
    Mol Carcinog; 2021 Dec; 60(12):859-873. PubMed ID: 34551139
    [Abstract] [Full Text] [Related]

  • 22. RUNX3 inhibits the invasion and migration of esophageal squamous cell carcinoma by reversing the epithelial‑mesenchymal transition through TGF‑β/Smad signaling.
    Xiao Z, Tian Y, Jia Y, Shen Q, Jiang W, Chen G, Shang B, Shi M, Wang Z, Zhao X.
    Oncol Rep; 2020 Apr; 43(4):1289-1299. PubMed ID: 32323849
    [Abstract] [Full Text] [Related]

  • 23. HAb18G/CD147 promotes epithelial-mesenchymal transition through TGF-β signaling and is transcriptionally regulated by Slug.
    Wu J, Ru NY, Zhang Y, Li Y, Wei D, Ren Z, Huang XF, Chen ZN, Bian H.
    Oncogene; 2011 Oct 27; 30(43):4410-27. PubMed ID: 21532623
    [Abstract] [Full Text] [Related]

  • 24. FAT1 prevents epithelial mesenchymal transition (EMT) via MAPK/ERK signaling pathway in esophageal squamous cell cancer.
    Hu X, Zhai Y, Kong P, Cui H, Yan T, Yang J, Qian Y, Ma Y, Wang F, Li H, Cheng C, Zhang L, Jia Z, Li Y, Yang B, Xu E, Wang J, Yang J, Bi Y, Chang L, Wang Y, Zhang Y, Song B, Li G, Shi R, Liu J, Zhang M, Cheng X, Cui Y.
    Cancer Lett; 2017 Jul 01; 397():83-93. PubMed ID: 28366557
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Role of SIRT1 in regulation of epithelial-to-mesenchymal transition in oral squamous cell carcinoma metastasis.
    Chen IC, Chiang WF, Huang HH, Chen PF, Shen YY, Chiang HC.
    Mol Cancer; 2014 Nov 26; 13():254. PubMed ID: 25424420
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma.
    Abudureheman A, Ainiwaer J, Hou Z, Niyaz M, Turghun A, Hasim A, Zhang H, Lu X, Sheyhidin I.
    J Cancer Res Clin Oncol; 2018 Jun 26; 144(6):1025-1035. PubMed ID: 29532228
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Myosin 5a regulates tumor migration and epithelial-mesenchymal transition in esophageal squamous cell carcinoma: utility as a prognostic factor.
    Sato N, Fujishima F, Nakamura Y, Aoyama Y, Onodera Y, Ozawa Y, Ito K, Ishida H, Kamei T, Watanabe M, Sasano H.
    Hum Pathol; 2018 Oct 26; 80():113-122. PubMed ID: 29898384
    [Abstract] [Full Text] [Related]

  • 32. Loss of miR-200b promotes invasion via activating the Kindlin-2/integrin β1/AKT pathway in esophageal squamous cell carcinoma: An E-cadherin-independent mechanism.
    Zhang HF, Alshareef A, Wu C, Li S, Jiao JW, Cao HH, Lai R, Xu LY, Li EM.
    Oncotarget; 2015 Oct 06; 6(30):28949-60. PubMed ID: 26334393
    [Abstract] [Full Text] [Related]

  • 33. MiRNA-34a reversed TGF-β-induced epithelial-mesenchymal transition via suppression of SMAD4 in NPC cells.
    Huang G, Du MY, Zhu H, Zhang N, Lu ZW, Qian LX, Zhang W, Tian X, He X, Yin L.
    Biomed Pharmacother; 2018 Oct 06; 106():217-224. PubMed ID: 29960168
    [Abstract] [Full Text] [Related]

  • 34. Novel ESCC-related gene ZNF750 as potential Prognostic biomarker and inhibits Epithelial-Mesenchymal Transition through directly depressing SNAI1 promoter in ESCC.
    Kong P, Xu E, Bi Y, Xu X, Liu X, Song B, Zhang L, Cheng C, Yan T, Qian Y, Yang J, Ma Y, Cui H, Zhai Y, Zou B, Liu X, Cheng Y, Guo S, Cheng X, Cui Y.
    Theranostics; 2020 Oct 06; 10(4):1798-1813. PubMed ID: 32042337
    [Abstract] [Full Text] [Related]

  • 35. Relationship between TWIST expression and epithelial-mesenchymal transition of oesophageal squamous cell carcinoma.
    Gao Y, Xuan XY, Zhang HY, Wang F, Zeng QR, Wang ZQ, Li SS.
    Cell Biol Int; 2012 Jun 01; 36(6):571-7. PubMed ID: 22360285
    [Abstract] [Full Text] [Related]

  • 36. miR-32 promotes esophageal squamous cell carcinoma metastasis by targeting CXXC5.
    Liu YT, Zong D, Jiang XS, Yin L, Wang LJ, Wang TT, Zhu J, He X.
    J Cell Biochem; 2019 Apr 01; 120(4):6250-6263. PubMed ID: 30362164
    [Abstract] [Full Text] [Related]

  • 37. TGF-β-activated SMAD3/4 complex transcriptionally upregulates N-cadherin expression in non-small cell lung cancer.
    Yang H, Wang L, Zhao J, Chen Y, Lei Z, Liu X, Xia W, Guo L, Zhang HT.
    Lung Cancer; 2015 Mar 01; 87(3):249-57. PubMed ID: 25595426
    [Abstract] [Full Text] [Related]

  • 38. SUMO-Specific Cysteine Protease 1 Promotes Epithelial Mesenchymal Transition of Prostate Cancer Cells via Regulating SMAD4 deSUMOylation.
    Zhang X, Wang H, Wang H, Xiao F, Seth P, Xu W, Jia Q, Wu C, Yang Y, Wang L.
    Int J Mol Sci; 2017 Apr 12; 18(4):. PubMed ID: 28417919
    [Abstract] [Full Text] [Related]

  • 39. Baicalein inhibits migration and invasion of gastric cancer cells through suppression of the TGF-β signaling pathway.
    Chen F, Zhuang M, Peng J, Wang X, Huang T, Li S, Lin M, Lin H, Xu Y, Li J, Chen Z, Huang Y.
    Mol Med Rep; 2014 Oct 12; 10(4):1999-2003. PubMed ID: 25109410
    [Abstract] [Full Text] [Related]

  • 40. Silencing SIX1 inhibits epithelial mesenchymal transition through regulating TGF-β/Smad2/3 signaling pathway in papillary thyroid carcinoma.
    Min WP, Wei XF.
    Auris Nasus Larynx; 2021 Jun 12; 48(3):487-495. PubMed ID: 33077306
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.